Mobile Site ›
Normal View

Test ID: RUA
Urinalysis, Complete, Includes Microscopic

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Useful For Suggests clinical disorders or settings where the test may be helpful

Screening for urinary tract diseases and some nonrenal diseases

Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.

Test IDReporting NameAvailable SeparatelyAlways Performed
SRC3SourceNoYes
APP4AppearanceNoYes
UOSMUOsmolality, UYesYes
PHU_pH, UYesYes
GLUCGlucoseYes, (Order RGLUR)Yes
PRO5ProteinYes, (Order RPTU)Yes
PR_OSProtein/OsmolalityNoYes
P24HPPredicted 24 Hr ProteinNoYes
P_RGEPredicted RangeNoYes
UBILBilirubinYes, (Order UBILU)No
HGBQLHemoglobin, QLYes, (Order HGB_Q)Yes
UREDUReducing Substance, UYes, (Available separately internally only)No
CMT51CommentNoYes

Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)

Test IDReporting NameAvailable SeparatelyAlways Performed
MICAMicroscopic AutomatedNoNo
MICMMicroscopic ManualNoNo

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.

When this test is ordered, either automated or manual microscopic examination will always be performed at no additional charge.

Method Name A short description of the method used to perform the test

Includes protein (quantitative; QN), glucose (QN), osmolality (QN), pH (QN), hemoglobin (semi-quantitative), and microscopic examination

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

Urinalysis Complete w/ Microscopic

Aliases Lists additional common names for a test, as an aid in searching

Microscopic, Urinalysis

Specimen Type Describes the specimen type needed for testing

Urine

Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.

Container/Tube: Plastic urine container

Specimen Volume: 20 mL (minimum volume: 4 mL) from a random urine collection

Collection Instructions: No preservative.

Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.

4 mL

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected

Hemolysis

NA

Lipemia

NA

Icterus

NA

Other

NA

 

Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.

Specimen TypeTemperatureTime
UrineRefrigerated72 hours

Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test

The kidney plays a key role in the excretion of by-products of cellular metabolism and regulation of water, acid-base, and electrolyte balance. Urine is produced by filtration of plasma in the renal glomeruli, followed by tubular secretion and/or reabsorption of water and other compounds.

 

Abnormalities detected by urinalysis may reflect either urinary tract diseases (eg, infection, glomerulonephritis, loss of concentrating capacity) or extrarenal disease processes (eg, glucosuria in diabetes, proteinuria in monoclonal gammopathies, bilirubinuria in liver disease).

Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.

Descriptive report

Interpretation Provides information to assist in interpretation of the test results

Microscopy:

RBCs, WBCs, renal tubular epithelial (RTE) cells, transitional epithelial cells, squamous epithelial cells, casts, sperm, free fat, oval fat bodies, bacteria, and pathologic crystals are reported. RBC casts are almost always indicative of glomerulonephritis. White cell casts are typically an indication of acute interstitial nephritis or pyelonephritis, but can also be seen in glomerulonephritides because there is often a component of accompanying interstitial nephritis. Fatty casts and free fat are often seen in patients with nephrotic syndrome or other glomerular diseases associated with significant proteinuria. Granular casts are observed in a number of disorders and are thought to be formed from partially degraded cellular casts, or are protein-derived casts. Hyaline casts are not thought to be indicative of any disease process, but increased numbers may be seen in concentrated urine specimens. Waxy casts and broad casts are most often observed in advanced renal failure. Increased numbers of RTE cells are indicators of renal tubular injury. Increased numbers of RTE may be caused by drugs with renal tubular toxicity (eg, cyclosporine A, aminoglycosides, cisplatin, radio-contrast media, acetaminophen overdose), interstitial nephritis, hypotension (surgical, sepsis, obstetric complications), or heme pigments from hemoglobinuria or myoglobinuria from rhabdomyolysis (eg, alcoholism, heat stroke, seizures, sickle cell trait). Newborns often shed RTE cells in their urine. The presence of squamous cells suggest that the specimen may not have been an optimal clean-catch specimen and could be contaminated with skin flora.

 

Recommendations by an American Urological Association panel, based upon careful review of all available published outcome studies that contained results of detailed hematuria workups within actual patient populations, are that patients with more than 3 RBCs per high-power field in 2 out of 3 properly collected urine specimens should be considered to have microhematuria and, hence, evaluated for possible pathologic causes. However, the panel also noted that there is no absolute lower limit for hematuria, and risk factors for significant disease should be taken into consideration before deciding to defer an evaluation in patients with only 1 or 2 RBCs per high-power field. High-risk patients, especially those with a history of smoking or chemical exposure, should still be considered for a full urologic evaluation even after a properly performed urinalysis documented the presence of at least 3 RBCs per high-power field. In certain patients, even 1 or 2 RBCs per high-powered field might merit evaluation.(1)

 

Osmolality:

Osmolality is an index of the solute concentration of osmotically active particles, principally sodium, chloride, potassium, and urea; glucose can contribute significantly to the osmolality when present in substantial amounts. The ability of the kidney to maintain both tonicity and water balance of the extracellular fluid can be evaluated by measuring the osmolality of the urine. More information concerning the state of renal water handling or abnormalities of urine dilution or concentration can be obtained if urinary osmolality is compared to serum osmolality. Normally, the ratio of urine osmolality to serum osmolality is 1.0 to 3.0, reflecting a wide range of urine osmolality.

Reference Values:

0-12 months: 50-750 mOsm/kg

>12 months: 150-1,150 mOsm/kg

Please note above the age of 20 there is an age-dependent decline in the upper reference range of approximately 5 mOsm/kg/year.

 

Protein:

This test detects the presence of overt proteinuria (>300 mg/day). However, normal urinary protein excretion is <30 mg/day. The presence of microalbuminuria (30-300 mg/day) is not detected by this method. Overt proteinuria is seen in both renal (eg, glomerulonephritis, renal tubular diseases, pyelonephritis) and nonrenal diseases (eg, myeloma, congestive heart failure, dehydration).

Reference Values:

<18 years: < or =22 mg/dL

> or =18 years: < or =19 mg/dL

 

Glucose:

The test is specific for glucose. No other substance excreted in urine is known to give a positive result, including other reducing substances (eg, galactose, fructose, and lactose). This test may be used to determine whether the reducing substance found in urine is glucose. Glucosuria occurs when the renal threshold for glucose is exceeded (typically >180 mg/dL); this is most commonly, although not exclusively, seen in diabetes.

Reference Values: < or =15 mg/dL

 

pH:

Urine pH is affected by diet, medications, systemic acid-base disturbances, and renal tubular function. pH may affect urinary stone formation. For example, urine pH <6.0 may help reduce the tendency for calcium phosphate stones and pH >6.0 may reduce the tendency for uric acid stone formation.

 

Ketones:

Produced during metabolism of fat, increased ketones may occur during physiological stress conditions such as fasting, pregnancy, strenuous exercise, and frequent vomiting. In diabetics who are unable to efficiently utilize glucose due to a lack of insulin, starvation, or with other abnormalities of carbohydrate or lipid metabolism, ketones may appear in the urine in large amounts before serum ketone is elevated.

 

Bilirubin:

Bilirubinuria is an indicator of liver disease and biliary tract obstruction.

 

Hemoglobin:

Hemoglobinuria is an indicator of intravascular hemolysis. The test is equally sensitive to myoglobin as to hemoglobin. The presence of hemoglobin, in the absence of RBCs, is consistent with intravascular hemolysis. RBCs may be missed if lysis occurred prior to analysis; the absence of RBCs should be confirmed by examining a fresh specimen. The presence of myoglobin may be confirmed by MYOU/9274 Myoglobin, Urine.

 

Reducing Substances:

Urine can contain a variety of reducing substances (sugars [glucose, galactose, sucrose, fructose, lactose, maltose], ascorbic acid, drugs, etc), compounds so termed because of their ability to reduce cupric ions. The primary reducing substances of medical significance are the sugars, glucose (diabetes), and galactose (galactosemia). Other sugars may be found but are not of clinical significance. Because glucose also is detected by glucose-specific dipstick reagents, the test for reducing substances is performed to detect galactose.

Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances

Glucose:

Urine glucose monitoring for the management of diabetes mellitus has essentially been replaced by more accurate and reliable fingerstick blood glucose determination. Also, as a screening test for diabetes mellitus, urine glucose testing has a low sensitivity (though reasonably good specificity). Drugs: No interference was found at therapeutic concentrations using common drug panels. Normal neonatal infants during the first 10 to 14 days of life may excrete urine giving a positive reaction due to glucose, galactose, lactose, and fructose (Bickel, 1961). The hexokinase method on the chemistry analyzer is specific for glucose only.

 

Ketones:

Substances causing false-positive results are bromsulphalein, phenolsulfonphthalein, phenylketone, cephalosporin, aldose-reductive antienzyme, and L-Dopa. Fasting or starvation diets may cause positive results.

 

Hemoglobin:

Elevated specific gravity, elevated protein, and large amounts of ascorbic acid may cause false-negative results. Oxidizing substances such as hypochlorite and chlorine may cause false-positive results. The test is equally sensitive to hemoglobin and myoglobin. The presence of hemoglobin, in the absence of RBCs, is consistent with intravascular hemolysis. RBCs may be missed if lysis occurred prior to analysis; the absence of RBCs should be confirmed by examining a fresh specimen. The presence of myoglobin may be confirmed by MYOU/9274 Myoglobin, Urine.

 

Protein:

False-positive results may be obtained with highly buffered, alkaline urines and large amounts of hematuria. Contamination of the urine specimen with quaternary ammonium compounds (eg, from some antiseptics and detergents) or with skin cleansers containing chlorhexidine also may produce false-positive results. Microalbumin tests are necessary to pick up early increases in urine protein excretion.

 

Reducing Substances:

This test reacts with sufficient quantities of any reducing substance in the urine; it is not specific for glucose. Low specific gravity urines containing glucose may give slightly elevated results. Metabolites of some sulfa drugs and methapyrilene compounds may interfere with the sensitivity of the test. X-Ray contrast media in urine produces reduced and false-negative glucose results.

Method Description Describes how the test is performed and provides a method-specific reference

Protein:

Dye binding-pyrogallol red(Package insert: Wako Autokit Micro TP, Pyrogallol red. Wako Chemicals USA, Inc., Richmond, VA 23237)

 

Glucose:

Glucose hexokinase(Package insert: Glucose/HK application sheet. Boehringer Mannheim Corporation, Indianapolis, IN 46256)

 

Specific Gravity:

Refractometer

 

Ketone:

(Package insert: AUTION Sticks 9EB for urine chemistry, ARKRAY Inc., Japan, distributed by Iris Diagnostics, Chatsworth, CA 91311-5874)

 

Bilirubin:

(Package insert: Ictotest tablet for Urinalysis. Bayer Corporation, Diagnostics Division, Elkhart, IN 46515)

 

pH:

pH meter

 

Osmolality:

Freezing point depression

 

Hemoglobin:

(Package insert: AUTION Sticks 9EB for urine chemistry, ARKRAY Inc., Japan, distributed by Iris Diagnostics, Chatsworth, CA 91311-5874)

 

Reducing Substances:

(Package insert: Clinitest Reagent Tablets. Bayer Corporation, Diagnostics Division, Elkhart, IN 46515)

 

A microscopic examination is performed on urine sediments by conventional microscopy or by automation using the IRIS iQ200 Sprint. Determination of which method to use is made by visual inspection. If the urine is a clear, normal color and the amount is adequate (30 mL), the urine is analyzed on the IRIS iQ200 Sprint. All remaining urines have a manual microscopic examination performed on the sediment after centrifuging for 5 minutes at 1,400 RPM.

Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.

Monday through Sunday; Continuously

Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.

1 day

Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result

1 day

Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded

2 days

Performing Laboratory Location The location of the laboratory that performs the test

Rochester

Test Classification Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer's instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR), Investigation Use Only (IUO) product, or a Research Use Only (RUO) product.

This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.

81001

LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.

Result IDReporting NameLOINC Code
PHU_pH, U2756-5
UOSMUOsmolality, U2695-5
UREDUReducing Substance, U5809-9
SRC3SourceN/A
APP4Appearance5767-9
GLUCGlucoseIn Process
PRO5ProteinN/A
PR_OSProtein/OsmolalityN/A
P24HPPredicted 24 Hr ProteinN/A
P_RGEPredicted RangeN/A
UBILBilirubin5770-3
HGBQLHemoglobin, QL5794-3
CMT51CommentN/A